Uncertainty in the Tail of the Variant Creutzfeldt-Jakob Disease Epidemic in the UK

Despite low case numbers the variant Creutzfeldt-Jakob disease epidemic poses many challenges for public health planning due to remaining uncertainties in disease biology and transmission routes. We develop a stochastic model for variant CJD transmission, taking into account the known transmission routes (food and red-cell transfusion) to assess the remaining uncertainty in the epidemic. We use Bayesian methods to obtain scenarios consistent with current data. Our results show a potentially long but uncertain tail in the epidemic, with a peak annual incidence of around 11 cases, but the 95% credibility interval between 1 and 65 cases. These cases are predicted to be due to past food-borne transmissions occurring in previously mostly unaffected genotypes and to transmissions via blood transfusion in all genotypes. However, we also show that the latter are unlikely to be identifiable as transfusion-associated cases by case-linking. Regardless of the numbers of future cases, even in the absence of any further control measures, we do not find any self-sustaining epidemics.

[1]  J. Ironside,et al.  Validation of diagnostic criteria for variant Creutzfeldt–Jakob disease , 2010, Annals of Neurology.

[2]  S. Cousens,et al.  Variant Creutzfeldt‐Jakob disease in a transfusion recipient: coincidence or cause? , 2010, Transfusion.

[3]  Peter Rudge,et al.  Variant CJD in an individual heterozygous for PRNP codon 129 , 2009, The Lancet.

[4]  Xiaowei Wu,et al.  Branching Processes with Biological Applications , 2010 .

[5]  J. Ironside,et al.  Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey , 2009, BMJ : British Medical Journal.

[6]  M. Turner,et al.  An update on the assessment and management of the risk of transmission of variant Creutzfeldt‐Jakob disease by blood and plasma products , 2009, British journal of haematology.

[7]  SEAC Spongiform Encephalopathy Advisory Committee POSITION STATEMENT PREVALENCE OF SUBCLINICAL VARIANT CREUTZFELDT-JAKOB DISEASE INFECTIONS , 2008 .

[8]  A. Ghani,et al.  Is there the potential for an epidemic of variant Creutzfeldt–Jakob disease via blood transfusion in the UK? , 2007, Journal of The Royal Society Interface.

[9]  K. Dietz,et al.  Blood Transfusion and Spread of Variant Creutzfeldt-Jakob Disease , 2007, Emerging infectious diseases.

[10]  A. Ghani,et al.  Factors determining the potential for onward transmission of variant Creutzfeldt–Jakob disease via surgical instruments , 2006, Journal of The Royal Society Interface.

[11]  Suvankar Pal,et al.  Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report , 2006, The Lancet.

[12]  P. Bennett,et al.  vCJD and blood transfusion: risk assessment in the United Kingdom. , 2006, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[13]  Louise Matthews,et al.  Comparative evidence for a link between Peyer's patch development and susceptibility to transmissible spongiform encephalopathies , 2006, BMC infectious diseases.

[14]  J Mackenzie,et al.  Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. , 2006, Vox sanguinis.

[15]  Paul Clarke,et al.  Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility , 2005, Journal of The Royal Society Interface.

[16]  Mark Head,et al.  Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .

[17]  Antonio Giulivi,et al.  Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood , 2004, The Lancet.

[18]  M. Head,et al.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004, The Lancet.

[19]  Mark Penney,et al.  Prevalence of lymphoreticular prion protein accumulation in UK tissue samples , 2004, The Journal of pathology.

[20]  C. Chapman,et al.  Long‐term survival after blood transfusion: a population based study in the North of England , 2004, Transfusion.

[21]  K. Roth,et al.  Infectivity of Prion Protein Bound to Stainless Steel Wires: A Model for Testing Decontamination Procedures for Transmissible Spongiform Encephalopathies , 2004, Infection Control & Hospital Epidemiology.

[22]  J Mackenzie,et al.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.

[23]  A. Ghani,et al.  Short-term projections for variant Creutzfeldt-Jakob disease onsets , 2003, Statistical methods in medical research.

[24]  A. Ghani,et al.  Updated projections of future vCJD deaths in the UK , 2003 .

[25]  Cooper Jd,et al.  UK bovine carcass meat consumed as burgers, sausages and other meat products: by birth cohort and gender. , 2002 .

[26]  S. Bird,et al.  UK bovine carcass meat consumed as burgers, sausages and other meat products: by birth cohort and gender. , 2002, Journal of cancer epidemiology and prevention.

[27]  A. Valleron,et al.  Estimation of Epidemic Size and Incubation Time Based on Age Characteristics of vCJD in the United Kingdom , 2001, Science.

[28]  J. Collinge,et al.  Transmission of Scrapie by Steel-surface-bound Prions , 2001, Molecular medicine.

[29]  Richard J. Beckman,et al.  A Comparison of Three Methods for Selecting Values of Input Variables in the Analysis of Output From a Computer Code , 2000, Technometrics.

[30]  A. Alpérovitch,et al.  Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease , 1999, The Lancet.

[31]  N M Ferguson,et al.  Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[32]  R. G. Will,et al.  Predicting the CJD epidemic in humans , 1997, Nature.

[33]  Bradley P. Carlin,et al.  BAYES AND EMPIRICAL BAYES METHODS FOR DATA ANALYSIS , 1996, Stat. Comput..

[34]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[35]  R. Will,et al.  Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study , 2006, BMJ.

[36]  B. Chesebro,et al.  Transmissible Spongiform Encephalopathies , 1994, Definitions.